Auditing of client's facilities and operations forms a major part of our
activities.
We all have decades of experience of auditing and we have the expertise to be
able to audit any type of activity - from Research and Development through to
distribution activities, from active pharmaceutical ingredients to all types of
dosage form manufacture - against all the major international regulatory and
GMP standards, including EU, USA, Canada, Australia, WHO and numerous others.
Several of our staff are former UK regulatory inspectors, whilst others have held senior corporate
compliance auditing positions with major multinational pharmaceutical
companies.
Because of our experience
we are able to provide simple and pragmatic
advice that will benefit you, your patients
and your business.
The types of audit we regularly perform include .
Third Party Audits
We can assist you in your search for the ideal contractor by performing audits
on your behalf to any GMP standard you wish.
We can assess potential contract services for .
-
Production
-
Packing
-
Testing
-
Storage and distribution
-
Engineering
-
Computer software
-
Water System
-
Autoclaves
-
Raw material suppliers
and a range of other vendor and supplier services.
We will provide you with a detailed but balanced report, highlighting .
-
Company strengths
-
Company vulnerabilities
-
Recommendations for short, medium and long term remedial actions
-
Our overall recommendations as to the suitability of the contractor for your
needs
There are numerous advantages to using an independent
organisation such as ourselves for this work.
-
We have the necessary expertise
-
We can compare what we find with what we know is available elsewhere
-
The third party is more likely to be open with an independent group than with
the potential client and there are fewer concerns regarding confidentiality.
"Benchmarking" Audits: Lets us help you
improve your overall efficiency.
Sometimes it can feel very lonely in the pharmaceutical industry.
You work hard to implement technology and systems to provide what you consider
to be an acceptable level of quality assurance and GMP compliance in your
company, but it is often very difficult to know whether what you are doing is
in line with current industry "best practice" and how you compare with your
major competitors.
This is where we can help.
Our constant exposure to pharmaceutical companies, large and small, on a
worldwide basis allows us to be able to assess your facilities, procedures and
practices against current industry norms and to provide you with that key
information . "Are we well up with current industry standards? Have we gone
over the top? Where do we stand?"
We can help you to assess your position in the marketplace and can provide
sound, commonsense advice on how to move forward.
Mock Regulatory Audits
We regularly assist clients to prepare for an imminent
regulatory inspection by carrying out one or more "mock" regulatory audits in
advance of the real thing.
Consultants from David Begg Associates will visit the client's facility and
play the role of regulatory inspectors to carry out an inspection in the style
of the relevant regulatory body (FDA, MHRA, EMEA etc.).
Such an audit has several advantages for the client .
-
They receive an in-depth, impartial and professional
assessment of their current state of compliance with the regulatory
expectations of the relevant authority.
-
They receive a detailed, prioritised action plan for the rectification of areas
of non-compliance and vulnerability so that improvements can be made or
position statements prepared before the actual inspection.
-
Their staff receive vital "training" in the sorts of questions which are likely
to be asked during the inspection and how best to answer these questions, so
increasing the confidence level within the company.
-
They receive sound, practical support and advice in the run-up to the
inspection itself.
EU and FDA Inspection Readiness:
We have extensive experience of preparing
companies throughout the world to MHRA or other EU regulatory inspections and
our "success rate" is enviable.
Perhaps more surprising is our excellent record of preparing
European clients for FDA inspections. We offer many advantages over US based
consultancies in this respect .
-
We are totally familiar with FDA regulations and expectations
during inspections, resulting from our work with US based clients.
-
We have practical experience of how FDA carry out overseas
inspections, whereas many US consultancies have experience only of domestic
investigations, which are very different both in duration and focus.
-
We are Europeans with strong cultural links to Europe but we also share a
common language with the USA and we understand the US mentality. This allows us
to "bridge the gap" between European and US philosophies.
-
We are based in Europe, so the cost of using our services is lower than using
US based consultancies, and we are more accessible for support in the final
preparation phases.
Troubleshooting and Problem Solving
When you are very
close to a problem it can become difficult
to solve. A 'fresh pair of eyes' can
often help you solve problems - quickly.
Our team have considerable expertise
with helping
companies to systematically resolve problems
associated with their products, processes,
equipment and systems.
Due Diligence Audits
We regularly assist pharmaceutical companies,
investment banks etc. in the process of due diligence for potential
acquisitions, buy-ins, joint ventures and other investment projects.
Whilst others assess the financial health of companies, we can perform an
in-depth assessment of the regulatory compliance status of companies and/or
projects by reviewing .
-
Status of marketing approvals, applications etc.
-
Current complaints, adverse reactions etc in order to assess vulnerability
-
Current relationships with the major regulatory authorities
-
The quality of staff in key technical positions
-
The general levels of GMP compliance and investment needed to maintain GMP
compliance in the short, medium and long term
The frequency of enquiries from European investment banks and
venture capital organisations attests to the quality of our work in this area.
Please feel free to e-mail us with your specific problem. We will do our best
to assist.
CLICK
HERE
Return to
the top of the page
|
|